One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
EU elections: a moment for pan-European health
doi : 10.1016/S0140-6736(24)00576-2
Volume 403, Issue 10432, 23–29 March 2024, Page 1109
Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration
Emily Y Chew a
doi : 10.1016/S0140-6736(24)00229-0
Volume 403, Issue 10432, 23–29 March 2024, Pages 1110-1111
Can high-dose aflibercept satisfy unmet treatment needs in diabetic macular oedema?
Pierre-Henry Gabrielle a b c, Catherine Creuzot-Garcher a b
doi : 10.1016/S0140-6736(23)02760-5
Volume 403, Issue 10432, 23–29 March 2024, Pages 1111-1113
First Africa-based clinical trial for novel type 2 oral poliovirus vaccine
Laura V Cooper a, Isobel M Blake a
doi : 10.1016/S0140-6736(24)00053-9
Volume 403, Issue 10432, 23–29 March 2024, Pages 1113-1115
Urgent need for transformative change in NHS dentistry
Richard G Watt a, Michelle Stennett a, Caillin Redican b, Chris Vernazza c
doi : 10.1016/S0140-6736(24)00352-0
Volume 403, Issue 10432, 23–29 March 2024, Pages 1115-1117
Generative artificial intelligence and scientific publishing: urgent questions, difficult answers
Jessamy Bagenal a
doi : 10.1016/S0140-6736(24)00416-1
Volume 403, Issue 10432, 23–29 March 2024, Pages 1118-1120
UK Public Health Science 2024: a call for abstracts
Daniel R R Bradford a, Francesco Aletta b, UK Public Health Science conference organising committee â€
doi : 10.1016/S0140-6736(24)00527-0
Volume 403, Issue 10432, 23–29 March 2024, Pages 1120-1121
Offline: It's about more than a climate emergency
Richard Horton
doi : 10.1016/S0140-6736(24)00575-0
Volume 403, Issue 10432, 23–29 March 2024, Page 1122
Health care in crisis amid Haiti violence
Joe Parkin Daniels
doi : 10.1016/S0140-6736(24)00577-4
Volume 403, Issue 10432, 23–29 March 2024, Page 1123
South Korean doctors threaten mass resignation
Justin McCurry
doi : 10.1016/S0140-6736(24)00578-6
Volume 403, Issue 10432, 23–29 March 2024, Page 1124
Pivotal tuberculosis vaccine trial begins
doi : 10.1016/S0140-6736(24)00579-8
Volume 403, Issue 10432, 23–29 March 2024, Page 1125
Research in Focus: Gates MRI
Talha Burki
doi : 10.1016/S0140-6736(24)00580-4
Volume 403, Issue 10432, 23–29 March 2024, Page 1126
Andrew Kerkhoff: award-winning TB and HIV physician–scientist
Geoff Watts
doi : 10.1016/S0140-6736(24)00539-7
Volume 403, Issue 10432, 23–29 March 2024, Page 1127
Confronting the anti-gender movement
Angela Saini
doi : 10.1016/S0140-6736(24)00540-3
Volume 403, Issue 10432, 23–29 March 2024, Page 1128
Talking to human beings
Niall Boyce
doi : 10.1016/S0140-6736(24)00541-5
Volume 403, Issue 10432, 23–29 March 2024, Page 1129
Rendering deafness visible
Ruben E Verwaal a b
doi : 10.1016/S0140-6736(24)00250-2
Volume 403, Issue 10432, 23–29 March 2024, Pages 1130-1131
Sidney Wolfe
Andrew Green
doi : 10.1016/S0140-6736(24)00542-7
Volume 403, Issue 10432, 23–29 March 2024, Page 1132
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign
Marianne Shawe-Taylor c d, David Greenwood c, Agnieszka Hobbs a, Giulia Dowgier a, Rebecca Penn c, Theo Sanderson c, Phoebe Stevenson-Leggett a, James Bazire a, Ruth Harvey b, Crick COVID Serology Pipeline Investigators, Legacy Investigators, Vincenzo Libri d, George Kassiotis c e, Steve Gamblin c, Nicola S Lewis b, Bryan Williams d f, Charles Swanton c f, Sonia Gandhi c f, Edward J Carr c f, Mary Y Wu c, David L V Bauer c g, Emma C Wall c d
doi : 10.1016/S0140-6736(24)00316-7
Volume 403, Issue 10432, 23–29 March 2024, Pages 1133-1136
The importance of reporting accurate estimates of long COVID prevalence
Joshua Szanyi a, Samantha Howe a, Tony Blakely a
doi : 10.1016/S0140-6736(23)01120-0
Volume 403, Issue 10432, 23–29 March 2024, Pages 1136-1137
Where will rectal artesunate suppositories save lives?
James A Watson a b, Thomas J Peto b c, Nicholas J White b c
doi : 10.1016/S0140-6736(23)01794-4
Volume 403, Issue 10432, 23–29 March 2024, Pages 1137-1138
New certificate verification guidelines for Nigerian nurses
Patrick Ashinze a
doi : 10.1016/S0140-6736(24)00370-2
Volume 403, Issue 10432, 23–29 March 2024, Page 1138
Australian medical leadership's silence on Gaza is a moral failure
Safiyyah Abbas a, Lucy Mitchell b
doi : 10.1016/S0140-6736(24)00401-X
Volume 403, Issue 10432, 23–29 March 2024, Pages 1138-1139
Threat level in the Gaza Strip: fatalities per 1000 person-years
Sheila M Bird a b
doi : 10.1016/S0140-6736(24)00402-1
Volume 403, Issue 10432, 23–29 March 2024, Pages 1139-1140
The universal right to health requires peace and rejects war
Carla Ancona a, Francesco Forastiere b, Pirous Fateh-Moghadam c
doi : 10.1016/S0140-6736(24)00403-3
Volume 403, Issue 10432, 23–29 March 2024, Page 1140
Department of Error
doi : 10.1016/S0140-6736(24)00543-9
Volume 403, Issue 10432, 23–29 March 2024, Page 1140
Department of Error
doi : 10.1016/S0140-6736(24)00493-8
Volume 403, Issue 10432, 23–29 March 2024, Page 1140
Department of Error
doi : 10.1016/S0140-6736(24)00544-0
Volume 403, Issue 10432, 23–29 March 2024, Page 1140
Department of Error
doi : 10.1016/S0140-6736(24)00545-2
Volume 403, Issue 10432, 23–29 March 2024, Page 1140
Department of Error
doi : 10.1016/S0140-6736(24)00546-4
Volume 403, Issue 10432, 23–29 March 2024, Page 1140
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
Prof Paolo Lanzetta MD a b *, Prof Jean-François Korobelnik MD c d *, Jeffrey S Heier MD e, Sergio Leal MD f, Prof Frank G Holz MD g, W Lloyd Clark MD h, David Eichenbaum MD i, Prof Tomohiro Iida MD j, Prof Sun Xiaodong MD k, Alyson J Berliner MD l, Andrea Schulze MS m, Thomas Schmelter PhD m, Ursula Schmidt-Ott MD m, Xin Zhang MD f, Robert Vitti MD l, Karen W Chu MS l, Kimberly Reed OD l, Rohini Rao MD l, Rafia Bhore PhD l, Yenchieh Cheng PhD l…Prof Tien Y Wong MD n o
doi : 10.1016/S0140-6736(24)00063-1
Volume 403, Issue 10432, 23–29 March 2024, Pages 1141-1152
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Prof David M Brown MD a, David S Boyer MD b, Prof Diana V Do MD c, Charles C Wykoff MD a d, Prof Taiji Sakamoto MD e, Peter Win MD f, Sunir Joshi MD g, Hani Salehi-Had MD h, András Seres MD i, Alyson J Berliner MD j, Sergio Leal MD k, Robert Vitti MD j, Karen W Chu MS j, Kimberly Reed OD j, Rohini Rao MD j, Yenchieh Cheng PhD j, Wei Sun PhD j, Delia Voronca PhD j, Rafia Bhore PhD j, Ursula Schmidt-Ott MD l…Shigeo Yoshida
doi : 10.1016/S0140-6736(23)02577-1
Volume 403, Issue 10432, 23–29 March 2024, Pages 1153-1163
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial
Magnus Ochoge MBChB a, Ahmed Cherno Futa MSc a, Ama Umesi MPH a, Lucy Affleck MBChB a, Larry Kotei MBChB a, Baboucarr Daffeh MBChB a, Ebrima Saidy-Jah MBChB a, Anna Njie MBChB a, Oluwafemi Oyadiran MBBS a, Bassey Edem MSc a, Musa Jallow MSc a, Edrissa Jallow MSc a, Simon A Donkor MSc a, Erman Tritama PhD b, Talha Abid MSc c, Kathryn A V Jones BS c, Bernardo A Mainou PhD c, John O Konz PhD d, Alan Fix MD d, Chris Gast PhD d †…Prof Ed Clarke MBChB a â€
doi : 10.1016/S0140-6736(23)02844-1
Volume 403, Issue 10432, 23–29 March 2024, Pages 1164-1175
Visualising facial distortions in prosopometamorphopsia
Antônio Mello BS a, Daniel Stehr PhD a, Krzysztof Bujarski MD b, Brad Duchaine PhD a
doi : 10.1016/S0140-6736(24)00136-3
Volume 403, Issue 10432, 23–29 March 2024, Page 1176
Crohn's disease
Michael Dolinger MD a, Joana Torres MD b c d, Prof Severine Vermeire MD e
doi : 10.1016/S0140-6736(23)02586-2
Volume 403, Issue 10432, 23–29 March 2024, Pages 1177-1191
mRNA-based therapeutics: looking beyond COVID-19 vaccines
Hamideh Parhiz PharmD PhD a †, Elena N Atochina-Vasserman MD PhD a †, Drew Weissman MD PhD a
doi : 10.1016/S0140-6736(23)02444-3
Volume 403, Issue 10432, 23–29 March 2024, Pages 1192-1204
